IFNA1 and COVID-19: They compared 50 COVID-19 patients divided into three different severity groups (compared to healthy controls) and found that severe disease progression was associated with a lower Interferon Signaling Gene (ISG) score, an impaired IFN-α production, and that it was associated with lower viral clearance (72).